Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Retained earnings (deficit)
Total
Beginning Balances at Dec. 31, 2019 $ 7 $ 6,710 $ 3,348 $ 10,065
Beginning Balances (in shares) at Dec. 31, 2019 6,959,063      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share issuance, net   102   102
Share issuance, net (in shares) 25,184      
Settlement of Payables   40   40
Settlement of payables (in shares) 10,000      
Stock-based compensation   456   456
Expected tax loss of future stock compensation option exercises   (288)   (288)
Equity component of convertible debt issuance   1,220   1,220
Fair value of finders' warrants   46   46
Net income (loss)     (14,711) (14,711)
Ending Balance at Sep. 30, 2020 $ 7 8,286 (11,363) (3,070)
Ending Balance (in shares) at Sep. 30, 2020 6,994,247      
Beginning Balances at Dec. 31, 2019 $ 7 6,710 3,348 10,065
Beginning Balances (in shares) at Dec. 31, 2019 6,959,063      
Ending Balance at Dec. 31, 2020 $ 11 30,886 (11,688) 19,209
Ending Balance (in shares) at Dec. 31, 2020 11,275,788      
Beginning Balances at Jun. 30, 2020 $ 7 8,056 (10,386) (2,323)
Beginning Balances (in shares) at Jun. 30, 2020 6,959,063      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share issuance, net   102   102
Share issuance, net (in shares) 25,184      
Settlement of Payables   40   40
Settlement of payables (in shares) 10,000      
Stock-based compensation   88   88
Net income (loss)     (977) (977)
Ending Balance at Sep. 30, 2020 $ 7 8,286 (11,363) (3,070)
Ending Balance (in shares) at Sep. 30, 2020 6,994,247      
Beginning Balances at Dec. 31, 2020 $ 11 30,886 (11,688) 19,209
Beginning Balances (in shares) at Dec. 31, 2020 11,275,788      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share issuance, net   832   832
Share issuance, net (in shares) 171,032      
Share issuance, acquisition related $ 1 2,274   2,275
Share issuance, acquisition related (in shares) 332,117      
Exercise of stock options   19   19
Exercise of stock options (in shares) 3,000      
Convertible debt converted into shares   60   60
Convertible debt converted into shares (in shares) 13,384      
Other (in shares) 15      
Stock-based compensation   818   818
Equity component of convertible debt issuance   1,203   1,203
Settlement of performance share liability   2,293   2,293
Settlement of performance share liability (in shares) 43,968      
Net income (loss)     (2,447) (2,447)
Ending Balance at Sep. 30, 2021 $ 12 38,385 (14,135) 24,262
Ending Balance (in shares) at Sep. 30, 2021 11,839,304      
Beginning Balances at Jun. 30, 2021 $ 12 38,136 (14,226) 23,922
Beginning Balances (in shares) at Jun. 30, 2021 11,833,431      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   19   19
Exercise of stock options (in shares) 3,000      
Convertible debt converted into shares   20   20
Convertible debt converted into shares (in shares) 2,858      
Other (in shares) 15      
Stock-based compensation   210   210
Net income (loss)     91 91
Ending Balance at Sep. 30, 2021 $ 12 $ 38,385 $ (14,135) $ 24,262
Ending Balance (in shares) at Sep. 30, 2021 11,839,304